Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
New Clues to Early Melanoma Development
June 2025
A new study uncovers how melanomas can arise from minimal genetic changes, shedding light on the early, often elusive steps in skin cancer progression
Read more
28 Mar 2017
Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24
Krakow, Poland / Berlin, Germany, March 28, 2017 – Selvita S.A. (WSE:SLV), and Berlin-Chemie Menarini, a company of the Menarini Group, announced today…
27 Mar 2017
Promising Results from Phase II Trial of Renal Cancer Drug
RESULTS published from a Phase II clinical trial have shown the potential of the investigational drug savolitinib in the treatment of c-MET-driven…
17 Mar 2017
Genomic Health Unveils a Wealth of Data for the Oncotype DX® Breast Cancer Test, Reinforcing Its Value in Improving Patient Outcomes and Leading to More Cost-Effective Management
Geneva, Switzerland, March 17, 2017 – Genomic Health today announced the presentation of 15 abstracts for the Oncotype DX® breast cancer test at the 15th…
14 Mar 2017
Cambridge-based Astex Pharmaceuticals Celebrates as Cancer Drug Receives US Marketing Approval
Cambridge, UK, March 13, 2017 – Astex Pharmaceuticals (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small…
13 Mar 2017
Selvita to Present New Data from its Oncology Programs at the Upcoming AACR Annual Meeting 2017
Kraków, Poland, March 13, 2017 – Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for oncology…
8 Mar 2017
German Community of Gynecological Oncology (AGO) Acknowledges MammaPrint in Breast Cancer Guidelines as Having Level 1A Clinical Evidence
Irvine, CA, USA and Amsterdam, the Netherlands, March 08, 2017 – Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics…
3 Mar 2017
Clinical and Preclinical Data on Monalizumab to Be Presented at AACR Annual Meeting 2017
Marseille, France, March 2, 2017 – Innate Pharma SA (the “Company” – Euronext Paris: FR0010331421 – IPH) today announces that data on monalizumab will be…
14 Feb 2017
Virtual Reality Project Awarded £20 Million in Funding for Cancer Research
CANCER RESEARCH UK has awarded millions in funding to scientists at the University of Cambridge, Cambridge, UK, who will build three-dimensional (3D)…
Loading posts...
« Previous
1
…
38
39
40
41
42
…
51
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View